CASTLE BIOSCIENCES, INC. Long-Term Debt
CASTLE BIOSCIENCES, INC. (CSTL) had Long-Term Debt of $7.16 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtNoncurrent · last filed 2026-07-30
- 2026-06-30: Long-term Debt, Excluding Current Maturities $7.16M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $8.40M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $9.64M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $10.05M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-06-30 | $7.16M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $8.40M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $9.64M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $10.05M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $8.10M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $8.92M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $9.74M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $10.02M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $10.01M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $10.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 | |
| 2020-12-31 | $0.00 10-K · filed 2021-03-11 | |
| 2020-09-30 | $12.46M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $14.74M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $17.01M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $19.29M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $21.57M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $23.86M 10-Q · filed 2019-09-03 | |
| 2018-12-31 | $24.50M 10-K · filed 2020-03-10 | $24.50M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |